POLYMEDNSE24 May 2022

Poly Medicure Limited

2,809words
2turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
: - 531768 The Manager, BSE Limited, Department of Corporate Services, Phirozee Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 . P lYMED MED ICAL DEV ICES We Care As We Cure Scrip Code:- POL
100%
peration 2001 Expansion of Faridabad Plant 2002 JV in Egypt 2004 Faridabad Plant-2 Extension (100% EOU) 2006 Acquired 75% of US Safety Syringes 2007 New Plant Haridwar 2009 China Plant 2011
75%
of Faridabad Plant 2002 JV in Egypt 2004 Faridabad Plant-2 Extension (100% EOU) 2006 Acquired 75% of US Safety Syringes 2007 New Plant Haridwar 2009 China Plant 2011 Company Listed in NSE
23%
etherlands Wholly owned Subsidiary (100%) Ultra for Medical Products Co. (UMIC) – Egypt Associate (23%) Plan 1 Health India Pvt. Ltd. Wholly owned Subsidiary (100%) Plan 1 Health Italy Step Down Subsi
34%
d Sales By Geography Polymed Sales By Product Category Polymed Brand and OEM Private Label Sales 34% 66% 12% 7% 5% 4% 9% 4% 3% 28% 63% 72% Export India Infusion Therapy Surgery & Wound
66%
es By Geography Polymed Sales By Product Category Polymed Brand and OEM Private Label Sales 34% 66% 12% 7% 5% 4% 9% 4% 3% 28% 63% 72% Export India Infusion Therapy Surgery & Wound Drain
12%
Geography Polymed Sales By Product Category Polymed Brand and OEM Private Label Sales 34% 66% 12% 7% 5% 4% 9% 4% 3% 28% 63% 72% Export India Infusion Therapy Surgery & Wound Drainage
7%
raphy Polymed Sales By Product Category Polymed Brand and OEM Private Label Sales 34% 66% 12% 7% 5% 4% 9% 4% 3% 28% 63% 72% Export India Infusion Therapy Surgery & Wound Drainage Bloo
5%
y Polymed Sales By Product Category Polymed Brand and OEM Private Label Sales 34% 66% 12% 7% 5% 4% 9% 4% 3% 28% 63% 72% Export India Infusion Therapy Surgery & Wound Drainage Blood Tr
4%
olymed Sales By Product Category Polymed Brand and OEM Private Label Sales 34% 66% 12% 7% 5% 4% 9% 4% 3% 28% 63% 72% Export India Infusion Therapy Surgery & Wound Drainage Blood Transf
9%
ed Sales By Product Category Polymed Brand and OEM Private Label Sales 34% 66% 12% 7% 5% 4% 9% 4% 3% 28% 63% 72% Export India Infusion Therapy Surgery & Wound Drainage Blood Transfusio
3%
By Product Category Polymed Brand and OEM Private Label Sales 34% 66% 12% 7% 5% 4% 9% 4% 3% 28% 63% 72% Export India Infusion Therapy Surgery & Wound Drainage Blood Transfusion Anaes
Speaking time
OUR STRENGTH
1
Registered Office
1
Advertisement
Opening remarks
OUR STRENGTH
Consistent all-round growth (Standalone) ₹ ₹ ₹ REVENUE (₹ Crs.) EBIDTA (₹ Crs.) PBT (₹ Crs.) PAT (₹ Crs.) 879.36 747.38 646.16 1000.00 800.00 600.00 400.00 200.00 0.00 250.00 200.00 150.00 100.00 50.00 0.00 208.30 212.13 160.14 Revenue EBIDTA 250.00 200.00 150.00 100.00 50.00 0.00 194.72 173.36 121.78 146.02 129.50 92.38 200.00 150.00 100.00 50.00 0.00 PBT PAT FY 2020 FY 2021 FY 2022 FY 2020 FY 2021 FY 2022 FY 2020 FY 2021 FY 2022 FY 2020 FY 2021 FY 2022 Year FY 2020 FY 2021 FY 2022 Revenue 646.16 747.38 879.36 Year FY 2020 FY 2021 FY 2022 EBIDTA % 160.14 24.78% 208.30 27.87% 212.13 24.12% Year FY 2020 FY 2021 FY 2022 PBT % 121.78 18.85% 173.36 23.20% 194.72 22.14% Year FY 2020 FY 2021 FY 2022 PAT % 92.38 14.30% 129.50 17.33% 146.02 16.60% Confidential I Slide 9 CREATING VALUE FOR SHAREHOLDERS Increasing Shareholders Base Creating Value for Shareholders 40000 35000 30000 25000 20000 15000 10000 5000 0 NO. OF SHAREHOLDERS 33831 21531 8574 No of Shareholders 31-03-2020 31-03-2021 31-03-2
Registered Office
232 B, 3rd Floor, Okhla Industrial Estate, Phase III, New Delhi-110020, India Tel:- 91-11-33550700, 47317000, 26321838/99 For any general queries, Reach us at: info@polymedicure.com Visit: www.polymedicure.com Confidential I Slide 21
Advertisement
← All transcriptsPOLYMED stock page →